Clinical investigation of medicinal products other than non-steroidal anti-inflammatory drugs (NSAIDs) for treatment of rheumatoid arthritis

  • Email
  • Help
Current effective version

Revision 1 - Points to consider

Currently under revision - see below

Reference numberCPMP/EWP/556/95 Rev. 1
Published17/12/2003
Effective from01/06/2004
KeywordsRheumatoid arthritis, disease modifying anti-rheumatic drugs, biologicals, clinical development
DescriptionThis document provides guidance on the evaluation of new medicinal products other than non-steroidal anti-inflammatory drugs for the treatment of rheumatoid arthritis.


Document history

Revision 2 

In progress

Draft guideline


Draft guideline


Concept paper

Published: 04/06/2015


Published: 20/12/2011


Published: 01/02/2010

Revision 1 

Current version

Points to consider

In operation: 01/06/2004–present


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more